Doha, 25 February 2025: Hamad Medical Corporation (HMC), the leading provider of specialist diabetes care in Qatar, continues to advance its commitment to world-class diabetes management through comprehensive, patient-centered care, innovative research, and multidisciplinary expertise.
“HMC is committed to providing world-class diabetes care that meets the highest international standards,” said Dr. Dabia Al-Mohanadi, Director of the Qatar Metabolic Institute. “Through innovation, multidisciplinary expertise, and cutting-edge research, we continue to enhance our services to improve patient outcomes and establish Qatar as a leader in diabetes management in the region.”
HMC’s National Diabetes Centers, located at Hamad General Hospital, Mesaieed Hospital, and the Women’s Wellness and Research Center, serve as premier facilities for specialist diabetes care. Designed as one-stop-shop treatment centers, they provide patients with access to expert consultations, individualized treatment plans, medications, and health education. With more than 120,000 patient visits annually, these centers cater to over 30,000 patients, reflecting the growing demand for advanced diabetes care in Qatar.
At the heart of HMC’s diabetes care model is a multidisciplinary team of physicians, nurses, diabetes educators, dietitians, podiatrists, pharmacists, and administrators working together to ensure the best possible outcomes for patients. Their mission is to prevent diabetes complications and support patients in leading healthy, fulfilling lives, while their vision is to establish HMC as a regional and international leader in diabetes management.
In recognition of HMC’s high standards of patient care, safety, and clinical excellence, HMC’s National Diabetes Centers have been awarded the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) for diabetes care. Achieving this recognition highlights the dedication of our multidisciplinary teams, who work tirelessly to improve patient outcomes and enhance the quality of care we provide. This certification is a testament to our unwavering commitment to excellence in diabetes care,” said Dr. Dabia Al-Mohanadi, Director of the Qatar Metabolic Institute in the Department of Medicine.
HMC is the first in the MENA region and only the sixth in the world to receive this prestigious certification, further solidifying its position as a center of excellence in diabetes management. JCI accreditation is widely regarded as the gold standard in global healthcare, and this recognition highlights HMC’s dedication to continuous improvement and innovation in diabetes management.
Recognizing the importance of early intervention, HMC’s Diabetes in Pregnancy Program ensures that all pregnant women in Qatar are screened for diabetes, with specialized care available at the National Diabetes Center at the Women’s Wellness and Research Center. This initiative is crucial in protecting maternal and neonatal health while addressing the rising prevalence of gestational diabetes.
Further cementing its position as a pioneer in diabetes care, HMC is home to the Qatar Diabetes Research Center, hosting the largest research-based diabetes prevention program in the region. This ambitious initiative, supported by the Qatar Research Development and Innovation Council and HMC’s Academic Health System, is dedicated to advancing scientific knowledge and implementing evidence-based strategies to prevent or delay Type 2 Diabetes in Qatar’s population.
